Literature DB >> 24867772

The association between spinal cord trauma-sensitive miRNAs and pain sensitivity, and their regulation by morphine.

Eric R Strickland1, Sarah A Woller2, Michelle A Hook2, James W Grau2, Rajesh C Miranda3.   

Abstract

Increased pain sensitivity is a common sequela to spinal cord injury (SCI). Moreover, drugs like morphine, though critical for pain management, elicit pro-inflammatory effects that exacerbate chronic pain symptoms. Previous reports showed that SCI results in the induction and suppression of several microRNAs (miRNAs), both at the site of injury, as well as in segments of the spinal cord distal to the injury site. We hypothesized that morphine would modulate the expression of these miRNAs, and that expression of these SCI-sensitive miRNAs may predict adaptation of distal nociceptive circuitry following SCI. To determine whether morphine treatment further dysregulates SCI-sensitive miRNAs, their expression was examined by qRT-PCR in sham controls and in response to vehicle and morphine treatment following contusion in rats, at either 2 or 15 days post-SCI. Our data indicated that expression of miR1, miR124, and miR129-2 at the injury site predicted the nociceptive response mediated by spinal regions distal to the lesion site, suggesting a molecular mechanism for the interaction of SCI with adaptation of functionally intact distal sensorimotor circuitry. Moreover, the SCI-induced miRNA, miR21 was induced by subsequent morphine administration, representing an alternate, and hitherto unidentified, maladaptive response to morphine exposure. Contrary to predictions, mRNA for the pro-inflammatory interleukin-6 receptor (IL6R), an identified target of SCI-sensitive miRNAs, was also induced following SCI, indicating dissociation between miRNA and target gene expression. Moreover, IL6R mRNA expression was inversely correlated with locomotor function suggesting that inflammation is a predictor of decreased spinal cord function. Collectively, our data indicate that miR21 and other SCI-sensitive miRNAs may constitute therapeutic targets, not only for improving functional recovery following SCI, but also for attenuating the effects of SCI on pain sensitivity.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dysregulation; MicroRNA; Morphine; Neuronal plasticity; Nociception; Spinal cord contusion

Mesh:

Substances:

Year:  2014        PMID: 24867772      PMCID: PMC4177361          DOI: 10.1016/j.neuint.2014.05.005

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  51 in total

1.  Anti-IL-6-receptor antibody promotes repair of spinal cord injury by inducing microglia-dominant inflammation.

Authors:  Masahiko Mukaino; Masaya Nakamura; Osamu Yamada; Seiji Okada; Satoru Morikawa; Francois Renault-Mihara; Akio Iwanami; Takeshi Ikegami; Yoshiyuki Ohsugi; Osahiko Tsuji; Hiroyuki Katoh; Yumi Matsuzaki; Yoshiaki Toyama; Meigen Liu; Hideyuki Okano
Journal:  Exp Neurol       Date:  2010-05-16       Impact factor: 5.330

2.  Modulation of inflammatory markers by miR-146a during replicative senescence in trabecular meshwork cells.

Authors:  Guorong Li; Coralia Luna; Jianming Qiu; David L Epstein; Pedro Gonzalez
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-06       Impact factor: 4.799

Review 3.  MicroRNA-146a and human disease.

Authors:  L Li; X-P Chen; Y-J Li
Journal:  Scand J Immunol       Date:  2010-04       Impact factor: 3.487

4.  Morphine treatment of human monocyte-derived macrophages induces differential miRNA and protein expression: impact on inflammation and oxidative stress in the central nervous system.

Authors:  Rajnish S Dave; Kamel Khalili
Journal:  J Cell Biochem       Date:  2010-07-01       Impact factor: 4.429

5.  Responses of microRNAs 124a and 223 following spinal cord injury in mice.

Authors:  K Nakanishi; T Nakasa; N Tanaka; M Ishikawa; K Yamada; K Yamasaki; N Kamei; B Izumi; N Adachi; S Miyaki; H Asahara; M Ochi
Journal:  Spinal Cord       Date:  2009-07-21       Impact factor: 2.772

6.  Intrathecal morphine attenuates recovery of function after a spinal cord injury.

Authors:  Michelle A Hook; Georgina Moreno; Sarah Woller; Denise Puga; Kevin Hoy; Robyn Balden; James W Grau
Journal:  J Neurotrauma       Date:  2009-05       Impact factor: 5.269

7.  Altered microRNA expression following traumatic spinal cord injury.

Authors:  Nai-Kui Liu; Xiao-Fei Wang; Qing-Bo Lu; Xiao-Ming Xu
Journal:  Exp Neurol       Date:  2009-07-01       Impact factor: 5.330

8.  Expression of microRNA-146 in rheumatoid arthritis synovial tissue.

Authors:  Tomoyuki Nakasa; Shigeru Miyaki; Atsuko Okubo; Megumi Hashimoto; Keiichiro Nishida; Mitsuo Ochi; Hiroshi Asahara
Journal:  Arthritis Rheum       Date:  2008-05

9.  Group I metabotropic glutamate receptors control metaplasticity of spinal cord learning through a protein kinase C-dependent mechanism.

Authors:  Adam R Ferguson; Kevin A Bolding; J Russell Huie; Michelle A Hook; Daniel R Santillano; Rajesh C Miranda; James W Grau
Journal:  J Neurosci       Date:  2008-11-12       Impact factor: 6.167

10.  miR-146a is critical for endotoxin-induced tolerance: IMPLICATION IN INNATE IMMUNITY.

Authors:  Md A Nahid; Kaleb M Pauley; Minoru Satoh; Edward K L Chan
Journal:  J Biol Chem       Date:  2009-10-19       Impact factor: 5.157

View more
  7 in total

Review 1.  Biomarkers in Spinal Cord Injury: from Prognosis to Treatment.

Authors:  Leonardo Fonseca Rodrigues; Vivaldo Moura-Neto; Tania Cristina Leite de Sampaio E Spohr
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

2.  The μ-opioid receptor induces miR-21 expression and is ERK/PKCμ-dependent.

Authors:  Jen-Kuan Chang; William D Cornwell; Thomas J Rogers
Journal:  J Neuroimmunol       Date:  2021-04-24       Impact factor: 3.221

3.  Regulatory effects of intermittent noxious stimulation on spinal cord injury-sensitive microRNAs and their presumptive targets following spinal cord contusion.

Authors:  Eric R Strickland; Sarah A Woller; Sandra M Garraway; Michelle A Hook; James W Grau; Rajesh C Miranda
Journal:  Front Neural Circuits       Date:  2014-09-18       Impact factor: 3.492

Review 4.  The Role of microRNA Markers in the Diagnosis, Treatment, and Outcome Prediction of Spinal Cord Injury.

Authors:  Nikolay L Martirosyan; Alessandro Carotenuto; Arpan A Patel; M Yashar S Kalani; Kaan Yagmurlu; G Michael Lemole; Mark C Preul; Nicholas Theodore
Journal:  Front Surg       Date:  2016-11-08

5.  Identification of candidate neoantigens produced by fusion transcripts in human osteosarcomas.

Authors:  Susan K Rathe; Flavia E Popescu; James E Johnson; Adrienne L Watson; Tracy A Marko; Branden S Moriarity; John R Ohlfest; David A Largaespada
Journal:  Sci Rep       Date:  2019-01-23       Impact factor: 4.996

6.  Roles of miRNAs in spinal cord injury and potential therapeutic interventions.

Authors:  Badria Almurshidi; Wayne Carver; Geoff Scott; Swapan K Ray
Journal:  Neuroimmunol Neuroinflamm       Date:  2019-10-17

7.  MicroRNAs Are Involved in the Development of Morphine-Induced Analgesic Tolerance and Regulate Functionally Relevant Changes in Serpini1.

Authors:  Jenica D Tapocik; Kristin Ceniccola; Cheryl L Mayo; Melanie L Schwandt; Matthew Solomon; Bi-Dar Wang; Truong V Luu; Jacqueline Olender; Thomas Harrigan; Thomas M Maynard; Greg I Elmer; Norman H Lee
Journal:  Front Mol Neurosci       Date:  2016-03-24       Impact factor: 5.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.